Log in to your Inderes Free account to see all free content on this page.
AstraZeneca
1,403
SEK
-3.64 %
Less than 1K followers
AZN
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-3.64%
-12.69%
-4.88%
-3.01%
-13.18%
-1.75%
+13.05%
+57.66%
+7,576.94%
AstraZeneca is a global biopharmaceutical company that focuses on the research, development, and marketing of prescription drugs, primarily for the treatment of diseases in the areas of therapy that affect the respiratory tract, cardiovascular / metabolism, and cancer. In addition to its main operations, the company is also active in autoimmunity, neuroscience, and infection. AstraZeneca is active in all global regions and is headquartered in Cambridge.
Read moreMarket cap
2.18T SEK
Turnover
1.03B SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
11.4.
2025
General meeting '25
29.4.
2025
Interim report Q1'25
All
Press releases
ShowingAll content types
AstraZeneca: Final Results
AstraZeneca licenses lipid lowering Lp(a) asset
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio